Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer
Clinical trial NCT01441947 · COMPLETED
Trial details
- NCT number
- NCT01441947
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2016-12-12
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.